Q5130 Pegfilgrastim-pbbk - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pegfilgrastim-pbbk

Brand Name:

Fylnetra

Strength:

0.5mg

HCPCS:

Q5130

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Immunostimulant

Minor Drug Class:

Granulocyte colony stimulating factor

Oral (Y/N):

No

FDA Approval Year:

2022

FDA Discontinuation Year:

CMS Effective Date:

March 17, 2023

CMS Discontinuation Date:

Status:

In Use